BridgeMD
New treatment option for Obsessive-Compulsive Disorder
Official title Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder
ClinicalTrials.gov ID: NCT04730011
What this study is testing
- What it's testing
- Obsessive-compulsive disorders are very damaging illnesses; they can already appear in childhood and adolescence and become extremely chronic. With an average prevalence from 1-3%, they are among the most common psychiatric disorders in children and adolescents.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 18
You may be able to join if
- Obsessive-Compulsive Disorder diagnosis
- Male and female patients from 8-18 years
- Good German language speaking skills
- IQ of at least 75
- At least four days' participation in the treatment/therapy week
You likely can't join if
- \- No complete participation in the intensive week treatment/therapy
See the full eligibility criteria
- Obsessive-Compulsive Disorder diagnosis
- Male and female patients from 8-18 years
- Good German language speaking skills
- IQ of at least 75
- At least four days' participation in the treatment/therapy week
- Written agreement after clear explanation
- \- No complete participation in the intensive week treatment/therapy
The study team makes the final eligibility decision.
Where it's taking place
- Zurich, Canton of Zurich, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zurich, Canton of Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.